Study of HemoCare™ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 5, 2019

Primary Completion Date

January 11, 2023

Study Completion Date

January 11, 2023

Conditions
End-Stage Renal Disease
Interventions
DEVICE

HemoCare™ Hemodialysis System

The HemoCare™ Hemodialysis System is intended for hemodialysis treatment, including short daily and nocturnal hemodialysis, of renal failure patients. The HemoCare™ Hemodialysis System is intended for use in chronic dialysis facilities, self-care dialysis facilities, or the home setting. All treatments must be prescribed by a physician and administered by a trained operator. Treatments must be performed under the supervision or assistance of a medical professional or a care partner who has been trained and deemed competent in the use of the device by the prescribing physician.

Trial Locations (8)

11021

The Rogosin Institute, New York

22908

University of Virginia, Charlottesville

37203

Dialysis Clinic, Inc., Nashville

37924

Dialysis Clinic Inc. - Knoxville, Knoxville

39213

University of Mississippi Medical Center, Jackson

78744

Wellbound South Austin, Austin

78758

Wellbound North Austin, Austin

08902

Dialysis Clinic, Inc - NJ, North Brunswick

Sponsors
All Listed Sponsors
collaborator

CVS Kidney Care LLC.

UNKNOWN

lead

Deka Research and Development

INDUSTRY

NCT04087213 - Study of HemoCare™ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD | Biotech Hunter | Biotech Hunter